Adel TABCHI (EL)
Chargé (e) d’enseignement
Faculté de médecine
+961 (1) 421 000 adel.tabshy@usj.edu.lb
Education
| Diplôme | Université | Pays | Année |
|---|---|---|---|
| Master - Oncologie | University of Texas at Austin | Etats-Unis | |
| Doctorat d'exercice - hématologie oncologie | University of Texas at Austin | Etats-Unis | 2007 |
Enseignement universitaire hors USJ
| Enseignement universitaire hors USJ | Pays | Etablissement | Date début | Date fin |
|---|---|---|---|---|
| Medical Oncology, Professor of Medicine | Etats-Unis | |||
| Medical Oncology, Faculty Member | Etats-Unis |
Expérience professionnelle hors USJ
| Expérience professionnelle | Organisation | Date début | Date fin |
|---|---|---|---|
| Attending Physician, Medical Oncology, Faculty Member | MD ANDERSON CANCER CENTER, HOUSTON, TX | 2007-07-01 | 2011-07-01 |
| Attending Physician, Medical Oncology, Professor of Medicine | Washington University in St Louis, School of Medicine | 2013-01-01 | 2015-03-01 |
Domaine d’expertise
Médecine et Santé
Thématiques de recherche
I am the recipient of NIH grants to investigate pathologic processes at the molecular level in Breast cancers. I am a clinical translational researcher. I investigate breast cancers.
Publications et communications
Adel Tabchy, Vicente Valero, Tatiana Vidaurre, Ana Lluch, Henry Gomez, Miguel Martin, Yuan Qi, Luis Javier Barajas-Figueroa, Eduardo Souchon, Charles Coutant, Franco D Doimi, Nuhad K Ibrahim, Yun Gong, Gabriel N Hortobagyi, Kenneth R Hess, W Fraser Symmans, Lajos Pusztai.
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.
Clinical Cancer Research. 2010 Nov 116(21):5351-61. Epub 2010 Sep 9.
- For rest of publications, see CV.
Anglais
Arabic